Organon (OGN) Equity Ratio (2020 - 2026)

Organon's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.07 for Q1 2026.

• In Q1 2026, Equity Ratio rose 68.66% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (up 68.66% YoY), while the FY2025 annual figure was 0.06, up 62.22% from the prior year.
• Equity Ratio was 0.07 for Q1 2026 at Organon, up from 0.06 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.07 in Q1 2026 to a low of 0.12 in Q1 2022.
• Historically, Equity Ratio has averaged 0.01 across 5 years, with a median of 0.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio plunged 124.09% in 2022, then jumped 920.59% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.08 in 2022, then soared by 92.87% to 0.01 in 2023, then soared by 720.6% to 0.04 in 2024, then soared by 62.22% to 0.06 in 2025, then climbed by 18.89% to 0.07 in 2026.
• The last three Equity Ratio figures came in at 0.07 (Q1 2026), 0.06 (Q4 2025), and 0.07 (Q3 2025), per Business Quant data.